Learn more about the Center’s latest research news, announcements, funding opportunities, program accomplishments and events in the monthly NCATS e-newsletter. Subscribe today!
As we close out 2019, take a look at a few of NCATS’ significant accomplishments and read about the key role of the NCATS-supported Porphyrias Consortium in developing the first drug to treat the rare, debilitating condition.
Looking for a previous article? View archived issues of the NCATS e-newsletter.